Leo Steenbergen

Alascom, Inc. provides communications services. It offers mobility, network Security and service, cloud, television, hosting and voice services. The company was founded 1969 and is headquartered in Anchorage, AK.

G-ray Switzerland SA is a private company based in Hauterive, Switzerland that was founded in 2014 by Patrick Scherrer, Hans von Känel, Daniel A. Rüfenacht, and Adolfo Fucci. The Swiss company specializes in radiographic imaging and new semiconductor assembly techniques, and has filed a number of revolutionary patents in these fields. The company has developed core skills in monolithic detectors with integrated high-resolution CMOS circuits, which have applications in various sectors such as automotive, aerospace, and medicine. Luis Pallares has been the CEO of the company since 2020.

G-Ray Medical Sàrl is a private company based in Hauterive, Switzerland. The Swiss company manufactures pixel array detectors for medical imaging. Luis Pallares has been the CEO of the company since 2020.

Sensimed SA develops non-invasive soft contact lens-based solutions. It offers solutions to monitor fluctuations in intraocular pressure continuously. The company was founded by Matteo Leonardi and Sacha Cerboni in 2003 and is headquartered in Lausanne, Switzerland.

Academic Medical Center operates a medical center and a medical research facility. It also provides education and training. The company was founded in 1983 and is headquartered in Amsterdam, the Netherlands.

Evolva SA is a Swiss-headquartered, international pharmaceutical biotech company focused on the discovery and development of drugs based on its distinctive and proprietary genetic chemistry platform. The company was founded in Switzerland in 2004 based on US/Danish technology. Evolva is headquartered in Allschwil/Basel with operations in Denmark, India and the USA. The Company has raised CHF 38.2 million of equity to date and employs 75 persons of whom 30 are based in Allschwil. The firm's strategy and business approach is based on five pillars that offer a sustainable development path for creating a successful company, which include Building a balanced portfolio. Evolva focuses on orally available small molecules in the belief that they are more convenient for patients and more cost-effective both from manufacture and administration points of view for the society, focus on differentiated pharmaceutical products with major benefits. Focusing on cardiovascular/renal and infectious diseases. Together they cause more than 50% of all deaths worldwide. Most of the top 20 pharmaceutical companies are active in both sectors, and all are active in one of the two sectors - hence widening Evolva's opportunities to partner. Building technology platform as the source of this differentiation. Evolva finds different structures with different properties from those found by the 99% of the industry that focuses on synthetic chemistry or proteins. Openness to unusual markets. The biotech business model has changed. As well as the established markets new opportunities arise in emerging countries such as India and China, and in adjacent sectors such as treatments against potential bio-terrorist and bio-warfare agents and the production of pharmaceutical and industrial chemical intermediates. Cost-effective implementation. Evolva places different functions around the globe according to where local conditions best suit. This approach both reduces Evolva's cost base and increases access to revenues, partners and talent. Evolva sees revenues and partners as important because they provide additional flexibility, resources and talent. Also, they provide important opportunities to better understand, and better meet, the needs of current and future customers.

Parnassia Groep BV provides mental care services. It offers care for ADHD, fear disorder, autism, cultural and psyche, depression, eating disorder, forensic problems, sexual disorders, and addictions. The company was founded on July 1, 2008 and is headquartered in the Hague, the Netherlands.

Amarna Therapeutics BV operates as a biotechnology company developing SVac viral gene delivery vector platform. The firm has developed a proprietary SuperVero cell line and SVec gene delivery platform for the development of safe and efficient immunotherapies for major indications within the degenerative, inflammatory and autoimmune disease areas. The company was founded by Ben van Leent and Peter de Haan in 2008 and is headquartered in Leiden, the Netherlands.

Wolters Kluwer Health, Inc. provides professional information services for professionals and students in medicine, nursing, allied health, and pharmacy. It offers bibliographic and reference databases, drug information software, point-of-care tools, web-based information systems, and online education products. The company was founded on October 29, 2001 and is headquartered in Philadelphia, PA.

Part of Elia Group SA/NV, Elia Transmission Belgium NV is a transmission system operator that operates at a European level. Based in Brussels, BE, Elia Transmission Belgium is leading the way in the energy revolution by developing diverse, sustainable, and reliable electrical systems on land and at sea. The Belgian company ensures the security of supply, serves its customers, and protects the safety of its personnel and subcontractors. Christiaan Peeters has been the CEO of the company since 2015.

DreamJet Participations SA operates as a holding company, with interest in the provision of air transportation services. The company is headquartered in Le Bourget, France.

NeuVasQ Biotechnologies SA develops pharmaceutical products to treat neurological disorders by repairing neurovascular function. The company is based in Gosselies, Belgium. The Belgian company was founded in 2021 by Benoit Vanhollebeke.

Armeos NV is a Belgian company that specializes in the protection and management of harmful organizations. The company is based in Nivelles, Belgium, and has subsidiaries in Belgium, France, and Poland. The company brings nature back into balance when it requires assistance. Armeos was founded in 2017, and the CEOs are Jean Klimis and Pierre Klimis.

Part of Elia Group SA/NV, Elia Asset SA engages in power generation and distribution services. The company is based in Brussels, Belgium. The Belgian company was founded in 2001. The CEO is Christiaan Peeters.

Pharmafluidics NV develops micro chip liquid chromatography cartridges for analysis of complex biological samples. The company was founded by Wim De Malsche, Joeri Denayer, Gert Desme and Paul Godelieve Jacobs in 2010 and is headquartered in Ghent, Belgium.

Credendo – Short-Term Non-EU Risks provides insurance and reinsurance services to businesses. The firm's insurance products include comprehensive policy, multinational policy and trade fairs and consignments. It also engages in the issuing of bonds. The company was founded in 2004 and is headquartered in Brussels, Belgium.

DIM3 SA develops decision support application software and medical devices. The firm offers Scorso, an app for the screening and follow-up of disease-related malnutrition; Nutrow, a decision support software for an optimization of clinical nutrition; and Biocorder, a connected clinical mobile assistant. The company was founded by Jean Claude Havaux on September 23, 2004 and is headquartered in Liege, Belgium.

Vifor Pharma Management AG develops and manufactures pharmaceuticals products for the treatment of iron deficiency. It also offers a diversified portfolio of prescription medicines as well as over-the-counter products. The company operates in the following key business areas: iron deficiency with and without anemia, kidney disease, infectious diseases/OTX products and consumer healthcare, with a focus on non-prescription products. Vifor Pharma Management was founded by Caspar Friedrich Hausmann in 1872 and is headquartered in Glattbrugg, Switzerland.

Banque Lombard Odier & Cie. SA provides financial services. The firm specialized in asset and wealth management, institutional asset management, and private banking services. It has a network of 24 offices in 17 countries. The company was founded in 1796 and is headquartered in Geneva, Switzerland.

SD Worx Sociaal Secretariaat VZW engages in the provision of payroll, human resources and legal solutions. It offers staffing, compensation and benefits, training courses, consulting, and research services. The company was founded on October 22, 1946 and is headquartered in Antwerp, Belgium.

Symeres provides molecule contract research, discovery, development and manufacturing services. The firm offers discovery chemistry, medicinal chemistry, early process research and GMP production services. The company is headquartered in Groningen, the Netherlands.

Atriva Therapeutics GmbH is a biopharmaceutical company that develops host-targeting antiviral therapies. It focuses on the development of new antiviral therapies against different respiratory viral infections. The company was founded by Rainer Lichtenberger and Henrik Luer Lueßen in April 2015 and is headquartered in Tuebingen, Germany.

Part of Rhythm Pharmaceuticals, Inc., Xinvento BV is a Dutch biotech company that develops therapies for congenital hyperinsulinism. The company is based in Amsterdam, Netherlands. The company was founded in 2021 by Claudine van der Sande, Sarah Hafith-de Boer, Piet Wigerinck. Claudine van der Sande has been the CEO since 2021. Xinvento was acquired by Rhythm Pharmaceuticals Netherlands BV on February 27, 2023 for $222.43 million.

miDIAGNOSTICS NV develops a computer chip powered portable medical laboratory. The company is headquartered in Leuven, Belgium.

University Hospital Antwerp provides clinical, patient care, academic training and scientific research services. The company was is headquartered in Belgium.

Drug Discovery & Development Solutions Ltd. engages in the provision of financial services. The company is headquartered in Singapore.